UK markets closed

Theravance Biopharma, Inc. (0TB.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
8.800.00 (0.00%)
As of 08:04AM CEST. Market open.
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts9987
Avg. Estimate-0.55-0.31-2.80.37
Low estimate-0.82-0.77-3.580.08
High estimate-0.35-0.04-2.030.71
Year ago EPS-1.16-0.92-4.46-2.8
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts8898
Avg. Estimate14.69M16.8M58.29M86.97M
Low estimate12M12.5M51.8M57.9M
High estimate19.5M25.68M69.64M123.55M
Year ago sales18.57M18.73M71.86M58.29M
Sales growth (year/est)-20.90%-10.30%-18.90%49.20%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.97-1.02-1.05-1.02
Actual EPS-1.16-0.92-1.24-0.8
Difference-0.190.1-0.190.22
Surprise %-19.60%9.80%-18.10%21.60%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.55-0.31-2.80.37
7 days ago-0.55-0.31-2.80.37
30 days ago-0.78-0.75-3.48-1.84
60 days ago-0.58-0.81-3.52-2.37
90 days ago-0.59-0.77-3.52-2.37
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/A1
Up last 30 days7778
Down last 7 daysN/AN/AN/AN/A
Down last 30 days11N/AN/A
Growth estimates0TB.FIndustrySector(s)S&P 500
Current qtr.52.60%N/AN/AN/A
Next qtr.66.30%N/AN/AN/A
Current year37.20%N/AN/AN/A
Next year113.20%N/AN/AN/A
Next 5 years (per annum)54.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A